This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Hartmut Scheffel: Innovating in Pharmaceutical Chemistry
Introduction
Hartmut Scheffel, an accomplished inventor based in Wuppertal, Germany, is known for his innovative contributions to the field of pharmaceutical chemistry. With a keen focus on the synthesis of complex chemical compounds, Scheffel has developed patented methods that enhance drug development processes.
Latest Patents
Scheffel holds a significant patent titled "Process for preparing tetrazole-substituted anthranilic acid diamide derivatives by reacting benzoxazinones with amines." This invention presents a novel process for preparing tetrazole-substituted anthranilic acid diamide derivatives, which play a crucial role in pharmaceutical applications. The patent outlines a method wherein benzoxazinones are reacted with amines to yield these valuable compounds, contributing to advancements in medicinal chemistry.
Career Highlights
Scheffel is currently employed at Bayer Intellectual Property GmbH, where he utilizes his expertise in chemical research and intellectual property. His work not only emphasizes innovation in chemical processes but also underscores the importance of protecting intellectual property through patents.
Collaborations
Throughout his career, Hartmut has collaborated with talented colleagues, including Sergii Pazenok and Werner Lindner. These collaborations reflect a strong team dynamic that fosters creativity and drives technological advancements in their field.
Conclusion
Hartmut Scheffel's contributions to pharmaceutical chemistry through his patent and collaborative efforts showcase the critical role of inventors in the innovation landscape. His work at Bayer Intellectual Property GmbH exemplifies how ingenuity and teamwork can lead to significant advancements, ultimately benefiting the medical field and society at large.